Azome Therapeutics Enters into CRADA with National Center for Advancing Translational Sciences to investigate novel inflammasome antagonist to prevent Bronchopulmonary Dysplasia.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    PR Newswire. 2024.